Stocks
Vanda Pharmaceuticals (VNDA) Debt/EBITDA US GAAP (year values) |
||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | |||
| Debt/EBITDA | -12.3 | -11.8 | -9.69 | -58.1 | 34.6 | 18.3 | ||
| Changes by years, y/y, % | +11% | -5% | -18% | +500% | -160% | |||
Vanda Pharmaceuticals. Debt/EBITDA
Vanda Pharmaceuticals. Debt/EBITDA, changes, %
Vanda Pharmaceuticals (VNDA) Debt/EBITDA US GAAP (quarter values) |
||||||||
| 2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
| Debt/EBITDA | -27.1 | -41.9 | -305.7 | 33.3 | 18.3 | 18.3 | ||
| Changes by years, y/y, % | +73% | +75% | +643% | -162% | -168% | |||
| Changes by quarters, q/q, % | -50% | +55% | +629% | -111% | -45% | |||
